shire map
Select a
Location

Shire Global

Newsroom

Director/PDMR Shareholding

March 11, 2016 – Shire plc (LSE: SHP, NASDAQ: SHPG) (the “Company”) announces it was notified today that Jeff Poulton, Chief Financial Officer of the Company, was granted a Restricted Stock award (the “Award”) today under the Shire Deferred Bonus Plan 2015 (“DBP”). The Award, which is in respect of 560 American Depositary Shares (“ADSs”), will normally vest after three years. The ADSs were acquired today on the NASDAQ Global Select Market at an average price of $163.0237 per ADS.

The DBP is a sub-plan of the Shire Long Term Incentive Plan 2015. The DBP has replaced the Shire Executive Annual Incentive Plan as referenced in the 2014 Annual Report and Accounts. One ADS is equal to three Ordinary Shares of 5 pence each in the Company.

This notification is to satisfy the Company’s obligations under 3.1.4(R)(1)(a) of the Disclosure Rules and Transparency Rules.

Oliver Strawbridge
Senior Assistant Company Secretary

For further information please contact:

Investor Relations

 

 

Sarah Elton-Farr

seltonfarr@shire.com

+44 1256 894157

NOTES TO EDITORS

Shire enables people with life-altering conditions to lead better lives.

Our strategy is to focus on developing and marketing innovative specialty medicines to meet significant unmet patient needs.

We focus on providing treatments in Rare Diseases, Neuroscience, Gastrointestinal and Internal Medicine and we are developing treatments for symptomatic conditions treated by specialist physicians in other targeted therapeutic areas, such as Ophthalmics.

www.shire.com

 

Cookie Use Notification

The site uses cookies to provide you with a more responsive and personalized service. By using this site you agree to our use of cookies as set out in our cookie notice. Please read our privacy notice for more information on the cookies we use and how to delete or block the use of cookies. LEARN MORE